tradingkey.logo

DSS Inc

DSS
0.918USD
-0.042-4.37%
收盤 12/31, 16:00美東報價延遲15分鐘
8.35M總市值
虧損本益比TTM

DSS Inc

0.918
-0.042-4.37%

關於 DSS Inc 公司

DSS, Inc. is a multinational, public company. The Company operates its business through five divisions: Product Packaging, Biotechnology, Commercial Lending, Securities and Investment Management, and Direct Marketing. The Product Packaging division operates through Premier Packaging Corporation, Inc., which markets, manufactures, and sells sophisticated custom folding cartons, mailers, photo sleeves and complex three-dimensional direct mail solutions. Biotechnology division targets unmet, urgent medical needs and expands the borders of medical and pharmaceutical science. Commercial Lending through its operating company, American Pacific Bancorp, Inc., which represents its banking and financing business line. The Direct Marketing is specialized in marketing and distributing its products and services through its subsidiary and partner network, using the gig economic marketing strategy as a form of direct marketing.

DSS Inc簡介

公司代碼DSS
公司名稱DSS Inc
上市日期Oct 27, 1993
CEOGrady (Jason)
員工數量100
證券類型Ordinary Share
年結日Oct 27
公司地址275 Wiregrass Pkwy
城市WEST HENRIETTA
上市交易所NASDAQ OMX – NASDAQ Basic Amex
國家United States of America
郵編14586
電話15852321500
網址https://www.dssworld.com/
公司代碼DSS
上市日期Oct 27, 1993
CEOGrady (Jason)

DSS Inc公司高管

名稱
名稱/職務
職務
持股
持股變動
Mr. Jason Grady
Mr. Jason Grady
Interim Chief Executive Officer
Interim Chief Executive Officer
125.00
--
Mr. Jose Escudero
Mr. Jose Escudero
Independent Director
Independent Director
51.00
--
Ms. Hiu Pan (Joanne) Wong
Ms. Hiu Pan (Joanne) Wong
Independent Director
Independent Director
--
--
Mr. Sheng Hon (Danny) Lim
Mr. Sheng Hon (Danny) Lim
Director
Director
--
--
Mr. Heng Fai (Ambrose) Chan
Mr. Heng Fai (Ambrose) Chan
Executive Chairman of the Board
Executive Chairman of the Board
--
--
Mr. Wai Leung (William) Wu
Mr. Wai Leung (William) Wu
Lead Independent Director
Lead Independent Director
--
--
Mr. Todd D. Macko
Mr. Todd D. Macko
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Tung Moe Chan
Mr. Tung Moe Chan
Director
Director
--
--
Mr. Shui Yeung (Frankie) Wong, CPA
Mr. Shui Yeung (Frankie) Wong, CPA
Independent Director
Independent Director
--
--
名稱
名稱/職務
職務
持股
持股變動
Mr. Jason Grady
Mr. Jason Grady
Interim Chief Executive Officer
Interim Chief Executive Officer
125.00
--
Mr. Jose Escudero
Mr. Jose Escudero
Independent Director
Independent Director
51.00
--
Ms. Hiu Pan (Joanne) Wong
Ms. Hiu Pan (Joanne) Wong
Independent Director
Independent Director
--
--
Mr. Sheng Hon (Danny) Lim
Mr. Sheng Hon (Danny) Lim
Director
Director
--
--
Mr. Heng Fai (Ambrose) Chan
Mr. Heng Fai (Ambrose) Chan
Executive Chairman of the Board
Executive Chairman of the Board
--
--
Mr. Wai Leung (William) Wu
Mr. Wai Leung (William) Wu
Lead Independent Director
Lead Independent Director
--
--

收入明細

單位: USD更新時間: 10月6日 週一
單位: USD更新時間: 10月6日 週一
FY2025Q2
FY2025Q1
FY2024
FY2023
FY2023Q1
FY2022
FY2022Q1
FY2021
FY2020
FY2019
業務USD
名稱
營收
佔比
Packaging Printing and Fabrication
4.15M
78.52%
Commercial and Security Printing
122.00K
2.31%
由於公司未披露,未能獲取相關數據
業務
地區
業務USD
名稱
營收
佔比
Packaging Printing and Fabrication
4.15M
78.52%
Commercial and Security Printing
122.00K
2.31%

股東統計

更新時間: 11月16日 週日
更新時間: 11月16日 週日
持股股東
股東類型
持股股東
持股股東
佔比
Alset Ehome International Inc
40.14%
Chan (Heng Fai Ambrose)
22.62%
Global Biomedical Pte Ltd.
3.43%
The Vanguard Group, Inc.
0.71%
Renaissance Technologies LLC
0.35%
其他
32.76%
持股股東
持股股東
佔比
Alset Ehome International Inc
40.14%
Chan (Heng Fai Ambrose)
22.62%
Global Biomedical Pte Ltd.
3.43%
The Vanguard Group, Inc.
0.71%
Renaissance Technologies LLC
0.35%
其他
32.76%
股東類型
持股股東
佔比
Corporation
43.57%
Individual Investor
22.62%
Investment Advisor
0.95%
Hedge Fund
0.37%
Investment Advisor/Hedge Fund
0.25%
Research Firm
0.03%
其他
32.21%

機構持股

更新時間: 12月8日 週一
更新時間: 12月8日 週一
報告期間
機構數
持股數
持股佔比
持股變動
2025Q4
35
145.92K
1.60%
-49.38K
2025Q3
36
145.92K
2.15%
-17.92K
2025Q2
35
163.84K
2.17%
-884.00
2025Q1
35
164.73K
1.72%
+7.88K
2024Q4
38
121.90K
3.03%
-50.52K
2024Q3
42
172.42K
3.04%
-10.61K
2024Q2
46
183.03K
2.83%
+19.66K
2024Q1
49
163.37K
2.83%
-36.31K
2023Q4
48
186.92K
3.41%
+16.51K
2023Q3
52
170.94K
7.14%
-2.49K
查看更多

股東持股明細

名稱
持股數
佔比
持股變動
變動比例
公告日期
Alset Ehome International Inc
3.65M
40.14%
-581.39K
-13.74%
Oct 06, 2025
Chan (Heng Fai Ambrose)
2.06M
22.62%
--
--
Oct 06, 2025
Global Biomedical Pte Ltd.
311.63K
3.43%
--
--
Oct 06, 2025
The Vanguard Group, Inc.
64.83K
0.71%
+43.10K
+198.36%
Sep 30, 2025
Renaissance Technologies LLC
31.45K
0.35%
+4.00K
+14.57%
Sep 30, 2025
Geode Capital Management, L.L.C.
22.84K
0.25%
+3.65K
+18.99%
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
20.98K
0.23%
--
--
Sep 30, 2025
Citi Investment Research (US)
2.94K
0.03%
+2.94K
--
Sep 30, 2025
Tower Research Capital LLC
2.54K
0.03%
-1.89K
-42.63%
Sep 30, 2025
Wells Fargo Advisors
157.00
0%
+155.00
+7750.00%
Sep 30, 2025
查看更多

持股ETF

更新時間: 12月6日 週六
更新時間: 12月6日 週六
機構名稱
佔比
iShares Core S&P Total U.S. Stock Market ETF
0%
iShares Core S&P Total U.S. Stock Market ETF
佔比0%

分紅派息

近5年累計派現 0.00 美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據

拆合股

公告日期
類型
比率
Nov 08, 2023
Merger
20→1
Nov 08, 2023
Merger
20→1
Nov 08, 2023
Merger
20→1
Nov 08, 2023
Merger
20→1
May 05, 2020
Merger
30→1
May 05, 2020
Merger
30→1
公告日期
類型
比率
Nov 08, 2023
Merger
20→1
Nov 08, 2023
Merger
20→1
Nov 08, 2023
Merger
20→1
Nov 08, 2023
Merger
20→1
May 05, 2020
Merger
30→1
May 05, 2020
Merger
30→1
May 05, 2020
Merger
30→1
May 05, 2020
Merger
30→1

常見問題

DSS Inc的前五大股東是誰?

DSS Inc的前五大股東如下:
Alset Ehome International Inc
持有股份:3.65M
佔總股份比例:40.14%。
Chan (Heng Fai Ambrose)
持有股份:2.06M
佔總股份比例:22.62%。
Global Biomedical Pte Ltd.
持有股份:311.63K
佔總股份比例:3.43%。
The Vanguard Group, Inc.
持有股份:64.83K
佔總股份比例:0.71%。
Renaissance Technologies LLC
持有股份:31.45K
佔總股份比例:0.35%。

DSS Inc的前三大股東類型是什麼?

DSS Inc 的前三大股東類型分別是:
Alset Ehome International Inc
Chan (Heng Fai Ambrose)
Global Biomedical Pte Ltd.

有多少機構持有DSS Inc(DSS)的股份?

截至2025Q4,共有35家機構持有DSS Inc的股份,合計持有的股份價值約為145.92K,占公司總股份的1.60% 。與2025Q3相比,機構持股有所增加,增幅為-0.54%。

哪個業務部門對DSS Inc的收入貢獻最大?

在FY2025Q2,Packaging Printing and Fabrication業務部門對DSS Inc的收入貢獻最大,創收4.15M,占總收入的78.52% 。
KeyAI